Cargando…

Intracellular dynamics of Ataxin-2 in the human brains with normal and frontotemporal lobar degeneration with TDP-43 inclusions

TAR DNA-binding protein of 43 kDa (TDP-43) is a major component of intracellular aggregates formed in brains of the patients with frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS), which are correctively referred to as TDP-43 proteinopathies. A link between Ataxin-2 (A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Ryohei, Higashi, Shinji, Nonaka, Takashi, Kawakami, Ito, Oshima, Kenichi, Niizato, Kazuhiro, Akiyama, Haruhiko, Yoshida, Mari, Hasegawa, Masato, Arai, Tetsuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594343/ https://www.ncbi.nlm.nih.gov/pubmed/33115537 http://dx.doi.org/10.1186/s40478-020-01055-9

Ejemplares similares

Chorea as a clinical feature of the basophilic inclusion body disease subtype of fused-in-sarcoma-associated frontotemporal lobar degeneration
por: Kawakami, Ito, et al.
Publicado: (2016)

Progranulin Deficiency Induces Mitochondrial Dysfunction in Frontotemporal Lobar Degeneration with TDP-43 Inclusions
por: Rodríguez-Periñán, Guiomar, et al.
Publicado: (2023)

TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration
por: Dijkstra, Anke A., et al.
Publicado: (2023)

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
por: Van Deerlin, Vivianna M., et al.
Publicado: (2010)

Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis
por: Tan, Rachel H., et al.
Publicado: (2017)

Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration
por: Yousef, Ahmed, et al.
Publicado: (2017)

TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration
por: Buciuc, Marina, et al.
Publicado: (2022)

Concurrent tau pathologies in frontotemporal lobar degeneration with TDP‐43 pathology
por: Koga, Shunsuke, et al.
Publicado: (2021)

TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration
por: Foulds, Penelope, et al.
Publicado: (2008)

Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration
por: Seelaar, Harro, et al.
Publicado: (2009)

In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology
por: Bocchetta, Martina, et al.
Publicado: (2020)

The basis of clinicopathological heterogeneity in TDP-43 proteinopathy
por: Kawakami, Ito, et al.
Publicado: (2019)

A 43-kDa TDP-43 Species Is Present in Aggregates Associated with Frontotemporal Lobar Degeneration
por: Bosque, Patrick J., et al.
Publicado: (2013)

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration
por: Urwin, Hazel, et al.
Publicado: (2010)

Tau accumulation in the nucleus accumbens in tangle-predominant dementia
por: Kawakami, Ito, et al.
Publicado: (2014)

The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients
por: Collins, Mahlon, et al.
Publicado: (2012)

TDP-43 cytoplasmic inclusion formation is disrupted in C9orf72-associated amyotrophic lateral sclerosis/frontotemporal lobar degeneration
por: Lee, Samuel M, et al.
Publicado: (2019)

Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations
por: Kocerha, Jannet, et al.
Publicado: (2011)

TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies
por: Goossens, Joery, et al.
Publicado: (2015)

Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy
por: Behrouzi, Roya, et al.
Publicado: (2016)

Reducing TDP-43 aggregation does not prevent its cytotoxicity
por: Liu, Rui, et al.
Publicado: (2013)

Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo
por: Porta, Sílvia, et al.
Publicado: (2018)

Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration
por: Riku, Yuichi, et al.
Publicado: (2021)

Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation
por: Hosokawa, Masato, et al.
Publicado: (2017)

Molecular Pathways Involved in Frontotemporal Lobar Degeneration with TDP-43 Proteinopathy: What Can We Learn from Proteomics?
por: Mol, Merel O., et al.
Publicado: (2021)

An autopsied FTDP-17 case with MAPT IVS 10 + 14C > T mutation presenting with frontotemporal dementia
por: Watanabe, Ryohei, et al.
Publicado: (2021)

Increased metal content in the TDP-43(A315T) transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis
por: Dang, Theresa N. T., et al.
Publicado: (2014)

Heterogeneous ribonuclear protein E2 (hnRNP E2) is associated with TDP-43-immunoreactive neurites in Semantic Dementia but not with other TDP-43 pathological subtypes of Frontotemporal Lobar Degeneration
por: Davidson, Yvonne S., et al.
Publicado: (2017)

ATP-binding cassette transporter expression is widely dysregulated in frontotemporal dementia with TDP-43 inclusions
por: Katzeff, Jared S., et al.
Publicado: (2022)

Fluorescence in-situ hybridization method reveals that carboxyl-terminal fragments of transactive response DNA-binding protein-43 truncated at the amino acid residue 218 reduce poly(A)(+) RNA expression
por: Higashi, Shinji, et al.
Publicado: (2018)

Therapeutic reduction of ataxin 2 extends lifespan and reduces pathology in TDP-43 mice
por: Becker, Lindsay A., et al.
Publicado: (2017)

(18)F-Flortaucipir in TDP-43 associated frontotemporal dementia
por: Smith, R., et al.
Publicado: (2019)

Cerebrospinal Fluid TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Patients with and without the C9ORF72 Hexanucleotide Expansion
por: Junttila, Anna, et al.
Publicado: (2016)

Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration
por: Cervantes González, Alba, et al.
Publicado: (2022)

Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology
por: Tisdall, M. Dylan, et al.
Publicado: (2021)

Tau and TDP-43 accumulation of the basal nucleus of Meynert in individuals with cerebral lobar infarcts or hemorrhage
por: Hatsuta, Hiroyuki, et al.
Publicado: (2019)

Accumulation of dipeptide repeat proteins predates that of TDP‐43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene
por: Baborie, Atik, et al.
Publicado: (2015)

Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP‐43 pathology and not associated with aggregated forms of dipeptide repeat proteins
por: Davidson, Y., et al.
Publicado: (2015)

TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Bright, Fiona, et al.
Publicado: (2021)

Frontotemporal Lobar Degeneration Case with an N-Terminal TUBA4A Mutation Exhibits Reduced TUBA4A Levels in the Brain and TDP-43 Pathology
por: Van Schoor, Evelien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_02jn59anc1mtdf61ephus3b2cj